Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Transplant
 More »

  • ATMI Supplies Bioreactor for Orgenesis, Takes $1.3M Stake
    shortages, and the risk of transplant rejection. "If successful, this could mean the end of diabetes as we now know it," Orgenesis declares on the homepage of its website. ...
    5-9-2013
  • People in the News
    Klingemann is a member of the board for Osiris Therapeutics. Previously, he was professor of medicine and director, bone marrow and stem cell transplant program at Tufts Medical ...
    4-15-2013
  • Transplanted Bioengineered Kidneys Successfully Produce Urine
    for donor kidneys or who are not transplant candidates could theoretically receive ... Even those fortunate enough to receive a transplant face a lifetime of immunosuppressive ...
    4-15-2013
  • Thermo Fisher's (Mostly) Buying Spree
    $2.2 billion as of December 31, 2012. September 13, 2012 - Completes acquisition of transplant diagnostics developer One Lambda for $925 million cash, a deal first disclosed July ...
    4-15-2013
  • AACR Rally for Medical Research
    But Boucher served as her donor for a bone marrow transplant at St. Jude's Children's Research and she is fine now. Her outcome was largely due to funded research that led to this ...
    4-8-2013
  • Is This Gene Therapy's Breakout Moment?
    ... You're not going to do that with just saline. Or if you do a bone marrow transplant, you're not going to do that without the gene. You also have to think about what are going to be ...
    4-1-2013
  • Development and Evolution of PCR
    ... mixtures such as post stem cell transplant engraftment monitoring. In the HLA field, serologic HLA typing, previously used for matching transplant donor and recipients as well as ...
    4-1-2013
  • Cell Therapy Leads to ALL Remission
    bone marrow transplant. Of those, three have remained in remission for between five and 24 months. A fourth died while in remission two months after the transplant from ...
    3-21-2013
  • Spectrum to Develop Ligand's PG-Free Melphalan
    of the chemotherapy drug being investigated for multiple myeloma transplant patients. ... treatment prior to autologous stem cell transplant for patients with multiple myeloma. ...
    3-14-2013
  • Is This Gene Therapy's Breakout Moment?
    ... You're not going to do that with just saline. Or if you do a bone marrow transplant, you're not going to do that without the gene. You also have to think about what are going to be ...
    3-4-2013
  • 3D Printing with Human Embryonic Stem Cells
    ... reliable, animal-free drug-testing and, in the longer term, to provide organs for transplant on demand, without the need for donation and without the problems of immune ...
    2-5-2013
  • Record Revenues for Thermo Despite "Challenging Environment"
    said it would shell out $925 million to buy One Lambda, a deal that expands Thermo Fisher's specialty diagnostics offering into the high-growth transplant diagnostics market. ...
    1-31-2013
  • NeoStem Subsidiary Signs Manufacturing Services Deal with Adaptimmune
    The clinical study was designed as a single-arm open-label study where patients are given standard of care (autologous stem cell transplant) in conjunction with engineered T cells. ...
    1-16-2013
  • The Schadt Equation
    ... Then came the offer to head Mount Sinai's Icahn Institute for Genomics and Multiscale Biology. Reluctant Transplant Dr. Schadt moved from California to New York in 2011. Although ...
    1-15-2013
  • CIRM Awards Over $6M to Two UCLA Cardiology Researchers
    To find out, he will transplant the heart stem cells into an animal model's injured heart to determine if the cells improve heart function. Dr. Ardehali also will perform detailed ...
    12-13-2012
  • More »

    Journal Articles

  • A New Sterilization Technique of Bovine Pericardial Biomaterial...
    Yury Shamis, Shital Patel, Alex Taube, Yos Morsi, Igor Sbarski, Yury Shramkov, Rodney J. Croft, Russell J. Crawford, Elena P. Ivanova
    Tissue Engineering, Part C: Methods
    Scanning electron microscopy imaging and cytotoxicity testing also confirmed that the structure and biocompatibility of transplant biomaterial remained unaltered after the ...
  • Assays on the Influence of Biomaterials on Allogeneic Rejection...
    Kim S. Jones
    Tissue Engineering, Part B: Reviews
    A major goal in tissue engineering is to induce transplant tolerance, potentially by manipulating the biomaterial component. This review describes methods of measuring responses of ...
  • Encapsulation of Pancreatic Islets Within Nano-Thin Functional...
    Seda Kizilel, Andrew Scavone, Xiang Liu, Jean-Manuel Nothias, Diane Ostrega, Piotr Witkowski, Michael Millis
    Tissue Engineering, Part A
    Therefore, a need exists to develop islet encapsulation strategies that minimize transplant volume. In this study, we demonstrate the formation of nano-thin, poly(ethylene glycol) ...
  • Bioceramic-Mediated Trophic Factor Secretion by Mesenchymal Stem...
    Jiawei He, Martin L. Decaris, J. Kent Leach, Jonathan Kent Leach
    Tissue Engineering, Part A
    The aim of this study was to determine the capacity of HA-PLG composites to co-transplant MSCs and ECFCs, with the goal of accelerating vascularization and resultant bone ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll